6669 — Acotec Scientific Holdings Balance Sheet
0.000.00%
- HK$2.94bn
- HK$2.13bn
- CNY644.63m
Annual balance sheet for Acotec Scientific Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,137 | 986 | 879 | 864 | 948 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 49.9 | 136 | 151 | 170 | 246 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,244 | 1,256 | 1,211 | 1,211 | 1,337 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 56.9 | 120 | 353 | 343 | 319 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,307 | 1,411 | 1,611 | 1,663 | 1,868 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 88.1 | 98.7 | 116 | 135 | 233 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 100 | 134 | 315 | 313 | 392 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 1,207 | 1,276 | 1,297 | 1,350 | 1,476 |
| Total Liabilities & Shareholders' Equity | 1,307 | 1,411 | 1,611 | 1,663 | 1,868 |
| Total Common Shares Outstanding |